Pinaverium Reduces Symptoms of Irritable Bowel Syndrome in a Multicenter, Randomized, Controlled Trial

Based on a controlled trial, pinaverium reduces symptoms of IBS. It can be considered a first-line treatment for IBS. Trial registration: NCT01641224 (www.ClinicalTrials.gov).